a phase 3 randomized controlled trial of resmetirom in nash（関連順）

2:17

Resmetirom for NASH with Liver Fibrosis | NEJM

NEJM Group

12,080 回視聴 - 7 か月前

19:29

Promising Phase 3 Data for Resmetirom Suggests It May Address ‘Monumental’ Unmet Need in NASH

HCPLive

1,649 回視聴 - 7 か月前

3:10

FDA Approves First Drug for Non-Alcoholic Steatohepatitis (NASH): Resmetirom Explained │PHARMACOLOGY

Pharmacology Insights

672 回視聴 - 4 か月前

5:17

5-Minute Check In: Evaluating the Use of Resmetirom in Patients with NASH and Liver Fibrosis

CommonSpirit Health Physician Enterprise

2 12 2024

S3-E34.1 - #ILC2022 Looking Back: Resmetirom Late-Breaker and Cirrhosis Study

Surfing MASH

246 回視聴 - 2 年前

11:07

S4-E30.2 - EASL Congress 2023: Scoring Systems to Evaluate NASH

24. Rohit Loomba

New Drug in MASLD

PCO Professional Academy

85 回視聴 - 2 か月前に配信済み

9:37

157. 밀크시슬보다 압도적으로 뛰어난 간장약(레스메티롬 - 팔란티어의 관점으로 분석해보자)

빅데이터닥터

3,513 回視聴 - 4 か月前

48:49

The Management of NASH: What does the future holds for us? by Naim Alkhouri, MD

INEDSYS Library

550 回視聴 - 1 年前

4:08:18

Use of Biomarkers for Diagnosing and Assessing Treatment Response in Noncirrhotic NASH Trials-D1-AM

U.S. Food and Drug Administration

1,156 回視聴 - 10 か月前

8:45

Liso-cel for CLL/SLL, Tislelizumab for Esophageal SCC, Resmetirom for NASH, Maralixibat for...

Nascent Medical

95 回視聴 - 6 か月前

14:05

S4-E32.1 - Lead Principle Investigator Stephen Harrison Recaps the MAESTRO-NASH Program for Resmetir

Surfing MASH

130 回視聴 - 1 年前

1:33:05

March 29 2022 MAFLD diagnosis and management webinar recording

EASO Obesity

335 回視聴 - 1 年前

33:31

EASL Studio S4E22 - JHEP Live: new and promising drugs for NASH on the horizon

EASL - Home of Hepatology

747 回視聴 - 1 年前

46:29

A Silent Epidemic Exploring Non Alcoholic Fatty Liver Disease

SHRI Academy

878 回視聴 - 1 か月前

7:32

Could New Drug Lower Cholesterol in lean people on a Keto diet?

Nick Norwitz

16,163 回視聴 - 6 か月前

38:08

Esteatosis Hepática | NASH / MASLD

Tutorías Medicina Interna

6,869 回視聴 - 1 か月前

15:07

Ihab Salem - Management of diabetes in patient with liver diseases

Xtreme

33 回視聴 - 10 日前

結果 : a phase 3 randomized controlled trial of resmetirom in nash